CenterWell Pharmacy, Inc.

3 cases as plaintiff.

Cases

Active

1 closed

Filed

2024

Top venue

S D N Y

2 cases

Watchlist

Get alerted when CenterWell Pharmacy, Inc. sues again.

Email-only, free, anonymous. We'll notify you when CenterWell Pharmacy, Inc. files another patent-infringement lawsuit. One-click unsubscribe from any alert.

CenterWell Pharmacy, Inc. v. Celgene Corp.

pending/consolidated

Court:: S.D.N.Y.
Filed:: 2024-09-13

Patents:8735428

π CenterWell Pharmacy, Inc.Δ Celgene Corp.

Antitrust action in which the '428 patent is cited as part of the challenged Celgene patent portfolio; CenterWell Pharmacy sued Celgene in S.D.N.Y. Status is generally pending/consolidated.

CenterWell Pharmacy, Inc. v. Celgene Corporation

pending/consolidated

Docket:: 1:24-cv-06924
Court:: S.D.N.Y.
Filed:: 2024-09-13

Patents:10555939

π CenterWell Pharmacy, Inc.Δ Celgene Corporation

Antitrust action in S.D.N.Y. naming the '939 formulation patent as part of an alleged monopolization scheme. Pending and consolidated with related Pomalyst antitrust actions.

CenterWell Pharmacy, Inc. v. Celgene Corp. et al.

unknown

Docket:: 1:23-cv-07871
Court:: U.S. District Court for the Southern District of New York (S.D.N.Y.)

Patents:10093647 10093648 10093649

π CenterWell Pharmacy, Inc.Δ Celgene Corp.Δ Bristol Myers Squibb Co.

CenterWell filed monopolization claims under Section 2 of the Sherman Act against Celgene and Bristol Myers Squibb, citing the '647/'648/'649 patents as part of an alleged pay-for-delay scheme.